CME Group (CME) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
3 Feb, 2026Opening remarks and agenda
Meeting commenced with introductions of board members, management, and recognition of retiring directors.
Representatives from Ernst & Young and Broadridge Financial Solutions were present to oversee accounting and election processes.
Agenda included two Q&A sessions: one for official proposals and one for general business.
Board and executive committee updates
Recognition of retiring board members Larry Gerdes, Dan Glickman, and Terry Savage for their service.
Existing Class B1, B2, and B3 directors will remain as holdovers due to lack of quorum for their election; one Class B2 director position remains vacant until 2026.
Shareholder proposals
Three proposals presented: election of 14 equity directors, ratification of Ernst & Young as auditor, and advisory vote on executive compensation.
Board recommended approval of all three proposals.
Latest events from CME Group
- Shareholders will vote on director elections, auditor ratification, and key governance amendments.CME
Proxy filing23 Mar 2026 - Shareholders to vote on major governance reforms, executive pay, and director elections.CME
Proxy filing23 Mar 2026 - Proposal to eliminate Class B director election rights, with payments to affected shareholders.CME
Proxy Filing12 Mar 2026 - Shareholders to vote on eliminating Class B director election rights amid record financial performance.CME
Proxy Filing12 Mar 2026 - Global growth, product innovation, and high margins drive record performance and shareholder returns.CME
47th Annual Raymond James Institutional Investor Conference3 Mar 2026 - Record 2025 growth fueled by innovation, global reach, and strong capital efficiencies.CME
Investor presentation3 Mar 2026 - Record revenue, earnings, and trading volumes in 2025, with strong capital returns.CME
Q4 20254 Feb 2026 - Record Q2 revenue, net income, and trading volumes, with growth in every asset class and strong margins.CME
Q2 20243 Feb 2026 - Strong volumes and global uncertainty drive growth focus in equities and credit, with regulatory vigilance.CME
Piper Sandler Global Exchange and Trading Conference 20241 Feb 2026